Sitemap
Pages
Industry sectors
- Pharmaceutical Industry
- Assay choices for early screening
- Access
- Chemical Industry
- Regulatory requirements
- Assay choices for early screening
- Access
- Agrochemical
- Access
- Fragrances and Flavours
- Regulatory requirements
- Access
- Personal Care Products
- Regulatory requirements
- Access
- Consumer Products
- Biomaterials and Biomedical Devices
- Access
- Contract Research Organisations
- Incorporate Gentonix assays into your portfolio
- Regulatory Environment
- Regulatory requirements
- Assay choices for early screening
- Assay choices for early screening
- Assay choices for early screening
- Regulatory Environment
- Assay choices for early screening
- Access
- Regulatory Environment
- Assay choices for early screening
- Access
Media Library
- Seeing the wood through the trees: a review of techniques for distinguishing green fluorescent protein from endogenous autofluorescence
- Fluorescence polarization discriminates green fluorescent protein from interfering autofluorescence in a microplate assay for genotoxicity
- Genotoxicity screening: The slow march to the future
- High-specificity and high-sensitivity genotoxicity assessment in a human cell line: Validation of the GreenScreen HC GADD45a-GFP genotoxicity assay
- Reducing late stage attrition with early high-throughput genotoxicity screening
- High throughput genotoxicity testing
- Interlaboratory assessment of the GreenScreen HC GADD45a-GFP genotoxicity screening assay: An enabling study for independent validation as an alternative method
- GADD45a-GFP GreenScreen HC genotoxicity screening assay
- Genotoxicity assessment in a changing world
- Evaluation of high-throughput genotoxicity assays used in profiling the US EPA ToxCast chemicals
- Analysis of 75 marketed pharmaceuticals using the GADD45a-GFP ‘GreenScreen HC’ genotoxicity assay
- Development and validation of a higher throughput screening approach to genotoxicity testing using the GADD45a-GFP GreenScreen HC assay
- Assessment of the genotoxicity of S9-generated metabolites using the GreenScreen HC GADD45a–GFP assay
- Genotoxic Carcinogen or not Genotoxic Carcinogen? That is the question. Additional analysis of data from Olaharski et al
- New Standards for Genotox
- A pre-validation transferability study of the GreenScreen HC GADD45a-GFP assay with a metabolic activation system (S9)
- GADD45a-GFP GreenScreen HC assay results for the ECVAM recommended lists of genotoxic and non-genotoxic chemicals for assessment of new genotoxicity tests
- Reducing Attrition due to Genotoxicity in Drug Discovery. High Throughput and Accurate Genotoxicity Screening with the GreenScreen HC Assay
- New and emerging technologies for genetic toxicity testing
- How accurate is in vitro prediction of carcinogenicity?
- BlueScreen HC – A luminescence based, high-throughput, in vitro genotoxicity assay.
- Shedding new light on the cosmetics testing industry
- in vitro predictions of in vivo genotoxicity are better than predictions of carcinogenicity
- Nongenotoxic apoptosis inducers do not produce misleading positive results in the TK6 cell-based GADD45a-GFP genotoxicity assay
- The GADD45a-GFP GreenScreen HC Assay
- Robustness and transferability study of a flow cytometric 96 well microplate based in vitro micronucleus assay
- Evaluation of the GADD45α-GFP GreenScreen HC assay for rapid and reliable in vitro early genotoxicity screening
- Development of a high-throughput Gaussia luciferase reporter assay for the activation of the GADD45a gene by mutagens, promutagens, clastogens, and aneugens.
- Making Sense of Safety
- The BlueScreen-384 Assay as an Indicator of Genotoxic Hazard Potential in Early-Stage Drug Discovery
- Moving attrition – Easier said than Done – The case for earlier genetic toxcicology prediction
- Predictive Toxicology in vitro – in vivo Strategy
- In vitro Micronucleus test to detect structural or numerical changes to chromosomes in cells exposed to a test compound
- GreenScreen® HC: an accurate and fast in vitro human cell-based assay for early genotoxicity screening
- Flow Cytometry method development and research in genetic toxicology and high-throughput screening
- In vitro alkaline comet assay to detect DNA damage
- BlueScreen™ HC: a luminescent genotoxicity assay for early screening
- In vitro AmesMPF™ bacterial reverse mutation screening assay for Ames test prediction
Products
- GreenScreen HC
- Assay Principles
- Access
- BlueScreen HC
- Assay Principles
- Results
- Access
- Micronucleus Test
- Assay principles
- Results
- Access
- Ames MPF
- Assay principles
- Access
- Comet Assay
- Assay Principles
- Access
- Flow Cytometry
- Custom Flow Services
- H2AX by Flow Cytometry
- Predictive Toxicology Services
- Results
- Results
- Cell Cycle Analysis by Flow Cytometry
- Access
- Results
People
Slideshow
Highlights
News
- Gentronix Participates in BIO-WISE Demonstrator Project
- Gentronix Honoured at Northwest’s First Biotechnology Awards
- Yeast Rises to Space Station Project
- Gentronix wins “Best Environmental Technology” Award
- Gentronix Completes Fund Raising Round.
- GreenScreen Helps Johnson & Johnson in Early Identification of Genotoxic Compounds.
- Gentronix Secures BBSRC R&D Award
- NeuroSolutions enters into a Collaboration Agreement with Gentronix
- GreenScreen for Environmental Monitoring Launched
- Gentronix Secures NC3R Grant Funding
- Next Generation Human Cell Genotoxicity Screen Unveiled at DDT 2006.
- Gentronix Wins NC3Rs Award
- NVM Invests £1 million in Gentronix
- BioReliance Launches Next-Generation Genotoxicity Screening Service
- GreenScreen HC presented to European Partnership for Alternative Approaches to Animal Testing
- Gentronix Announces Addition to its Executive Team and Board of Directors
- Gentronix Launches New Genotoxic Metabolite Detection Assay
- Manchester Scientists Highlighted for Contribution to UK Economy
- Gentronix use Abcellute Preserved Hepatocytes to Enhance in vitro Genotoxicity Testing
- Gentronix Goes East
- Gentronix Agrees Genotoxicity Safety Screening Agreement with GSK for GreenScreen HC
- Gentronix and Apredica Ally to Create Predictive-Toxicology Service
- Gentronix Signs 3 Year Agreement with GlaxoSmithKline for GreenScreen and BlueScreen Assays
- Gentronix launches BlueScreen HC and Expands Services with the Comet Assay
- Gentronix Ltd. Announces Rights Issue Completion
- Charles River Now Offers the Gentronix BlueScreen HC Genotoxicity Screening Test
- LGC Standards partners with Gentronix
- ADVANCELL partners with Gentronix to Offer Services to the Cosmetics and Personal Care Sector
- Gentronix Expands Early Genotoxicity Screening Capability with Ames MPF™ Screening Service
- Gentronix Becomes a Distributor of Litron Laboratories MicroFlow® Range of Products in Europe.
- Gentronix teams up with Paris-based BioQuanta to distribute Mitoxis – Functional Metabolic Platform
- Gentronix showcases technology and new partnerships.
- Gentronix expands specialist sales team in US and Europe
- Gentronix expands sales effort into Japan with Intralink Ltd.
- Gentronix announces first screening contract in Japan with Kowa
- First paper on use of BlueScreen HC accepted by “Journal of Biomolecular Screening”
- Independent evaluation of GreenScreen published by Galderma
- Gentronix Receives French Research Tax Credit Accreditation
- Innovative Early Stage Test For Personal Care Product Safety
- Gentronix Awarded Grant from the Biomedical Catalyst Programme for an Epigenetic Based Screening Assay Feasibility Study.
- New BlueScreen HC Publication from GSK
- Follow us on Twitter
- Meet Gentronix at SOT 2013
- Epigenetics presentation at ’ADME and Predictive Toxicology’ meeting
- Follow Gentronix on Twitter
- New Paper Sheds Light on Role of WT1 Protein in p53-Dependent and p53-Independent Pathways for GADD45a Regulation
- GreenScreen and BlueScreen to be discussed in IWGT Plenary Session